Best Genomics Software Companies in 2022

Request Free Sample Report
Genomics Market (Global) Company Evaluation Quadrant
Published on
Mar'2019
Pages
76
Code
360-BT 2209
Email
Share
Request Free Sample Report

Genomics is a branch of molecular biology which involves the study of the structure, function, evolution, and mapping of genomes. It applies sequencing methods and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of an organism. Genomics is widely used in diagnostics, personalized medicine, animal and agricultural research, forensics, fishery, and aquaculture research, among others.

The global genomics market is projected to reach USD 36 billion by 2024 from USD 19 billion in 2019, at a CAGR of 13% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the market. However, the high cost of genomic equipment could limit market growth to a certain extent in the coming years.

Rising government funding and number of genomics projects is driving the growth in the Genomics Market

This report identifies and benchmarks the best Genomics vendors such as Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US) and Eurofins Scientific (Germany), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the genomics ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. 25 Genomics vendors are evaluated, rated, and positioned, and 12 top companies (identified by * in below list) have been profiled on a 2x2 matrix, called ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies. This report also identifies and benchmarks the top genomics start-ups, positioned on a 2x2 matrix, and identified as Progressive Companies, Starting Blocks, Dynamic Companies, and Responsive Companies.

The report includes market-specific company profiles of 12 players and assesses the recent developments that shape the competitive landscape of this highly fragmented market.


List of top Genomics companies evaluated and profiled in the report:

  • AGILENT TECHNOLOGIES, INC.*
  • BGI*
  • BIODISCOVERY, INC.
  • BIONANO GENOMICS
  • BIO-RAD LABORATORIES, INC.*
  • CREATIVE BIOGENE
  • DANAHER CORPORATION*
  • EMPIRE GENOMICS, LLC
  • EPPENDORF AG*
  • EUROFINS SCIENTIFIC GROUP*
  • GE HEALTHCARE*
  • ILLUMINA, INC.*
  • MACROGEN
  • MERCK KGAA
  • NEW ENGLAND BIOLABS, INC.
  • NOVOGENE CORPORATION
  • OXFORD NANOPORE TECHNOLOGIES*
  • PHALANX BIOTECH GROUP
  • PROMEGA CORPORATION
  • QIAGEN N. V.*
  • ROCHE HOLDING AG*
  • SEQMATIC LLC
  • SOURCE BIOSCIENCE
  • THERMO FISHER SCIENTIFIC, INC.*
  • VERITAS GENETICS INTERNATIONAL LTD.

Table of Contents

1 Introduction
   1.1 Market Definition

2 Market Overview
   2.1 Introduction
   2.2 Market Dynamics
         2.2.1 Drivers
                   2.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                   2.2.1.2 Decreasing Sequencing Costs
                   2.2.1.3 Growing Application Areas of Genomics
                   2.2.1.4 Entry of New Players and Start-Ups in the Genomics Market
         2.2.2 Restraints
                   2.2.2.1 High Cost of Genomic Equipment
         2.2.3 Opportunities
                   2.2.3.1 Use of Genomics in Specialized/Personalized Medicine
         2.2.4 Challenges
                   2.2.4.1 Dearth of Trained Professionals
                   2.2.4.2 Secure Storage of Large Volumes of Sequenced Data

3 Company Evaluation Quadrant
   3.1 Visionary Leaders
   3.2 Innovators
   3.3 Dynamic Differentiators
   3.4 Emerging Companies
          Figure 1 Genomics Market (Global) Company Evaluation Quadrant
   3.5 Strength of Product Portfolio (25 Companies)
   3.6 Business Strategy Excellence (25 Companies)

4 Company Evaluation Quadrant – Startups
   4.1 Progressive Companies
   4.2 Dynamic Companies
   4.3 Responsive Companies
   4.4 Starting Blocks
          Figure 2 Genomics Market (Global) Company Evaluation Quadrant -Startups

5 Competitive Landscape
   5.1 Overview
          Figure 3 Genomics Market Share Analysis, By Key Player, 2018
          5.1.1 Thermo Fisher Scientific
          5.1.2 Illumina
          5.1.3 QIAGEN
          5.1.4 Others
   5.2 Competitive Scenario
         5.2.1 Product Launches and Approvals
                   Table 1 Product Launches and Approvals
         5.2.2 Expansions
                   Table 2 Expansions
         5.2.3 Agreements and Collaborations
                   Table 3 Agreements and Collaborations
         5.2.4 Acquisitions
                   Table 4 Acquisitions

6 Company Profiles
   6.1 Illumina, Inc.
         6.1.1 Business Overview*
                   Figure 4 Illumina, Inc.: Company Snapshot (2018)
         6.1.2 Products Offered*
         6.1.3 Services Offered*
         6.1.4 Recent Developments*
         6.1.5 MnM View*
         (*Above sections are present for all of below companies)
   6.2 Thermo Fisher Scientific
          Figure 5 Thermo Fisher Scientific, Inc.: Company Snapshot (2017)
   6.3 QIAGEN
          Figure 6 QIAGEN N.V.: Company Snapshot (2017)
   6.4 Eurofins Scientific
          Figure 7 Eurofins Scientific: Company Snapshot (2017)
   6.5 Agilent Technologies
          Figure 8 Agilent Technologies: Company Snapshot (2017)
   6.6 Oxford Nanopore Technologies
   6.7 F. Hoffmann-La Roche
          Figure 9 Roche Holding AG: Company Snapshot (2017) 
   6.8 Bio-Rad Laboratories
          Figure 10 Bio-Rad Laboratories, Inc.: Company Snapshot (2017)
   6.9 BGI
   6.10 Danaher Corporation
            Figure 11 Danaher Corporation: Company Snapshot (2017)
   6.11 GE Healthcare
            Figure 12 General Electrical Company: Company Snapshot (2017)
   6.12 Eppendorf
            Figure 13 Eppendorf AG: Company Snapshot (2017)

7 Appendix
   7.1 Methodology

This report identifies and benchmarks the best Genomics vendors such as Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US) and Eurofins Scientific (Germany), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the genomics ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. Best Genomics vendors are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies. This report also identifies and benchmarks the top genomics start-ups, positioned on a 2x2 matrix, and identified as Progressive Companies, Starting Blocks, Dynamic Companies, and Responsive Companies.

SAMPLES:





1450 USD
Licensing Options
Personalize Your Research Requirement
  • Updated version of this Quadrant
  • Different Company Evaluation Quadrant
  • 'Startup Only' Company Evaluation Quadrant
  • Region or Country specific evaluation
  • Application or Industry specific evaluation
  • ..Read More
Analyst Briefing & Inquiry
  • Submit a Briefing Request
  • Question about our published research
  • Request for evaluation of your organization for specific market
  • Request for re-evaluation of Company Evaluation Quadrant
  • ..Read More